Cargando…
Chronic cluster headache and the pituitary gland
BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788665/ https://www.ncbi.nlm.nih.gov/pubmed/26969187 http://dx.doi.org/10.1186/s10194-016-0614-0 |
_version_ | 1782420747849826304 |
---|---|
author | De Pue, Annelien Lutin, Bart Paemeleire, Koen |
author_facet | De Pue, Annelien Lutin, Bart Paemeleire, Koen |
author_sort | De Pue, Annelien |
collection | PubMed |
description | BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3 beta criteria fulfilled) since the age of 35 years. A magnetic resonance imaging (MRI) study of the brain in 2006 came back normal. He tried several prophylactic treatments but was never longer than 1 month without attacks. He was under chronic treatment with verapamil with only a limited effect on the attack frequency. Subcutaneous sumatriptan 6 mg injections were very effective in aborting attacks. By February 2014 the patient developed a continuous interictal pain ipsilateral to the right-sided cluster headache attacks. An indomethacin test (up to 225 mg/day orally) was negative. Because of the change in headache pattern we performed a new brain MRI, which showed a cystic structure in the pituitary gland. The differential diagnosis was between a Rathke cleft cyst and a cystic adenoma. Pituitary function tests showed an elevated serum prolactin level. A dopamine agonist (cabergoline) was started and the headache subsided completely. Potential pathophysiological mechanisms of pituitary tumor-associated headache are discussed. CONCLUSION: Neuroimaging should be considered in all patients with CCH, especially those with an atypical presentation or evolution. Response to acute treatment does not exclude a secondary form of cluster headache. There may be shared pathophysiological mechanisms of primary and secondary cluster headache. |
format | Online Article Text |
id | pubmed-4788665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-47886652016-04-09 Chronic cluster headache and the pituitary gland De Pue, Annelien Lutin, Bart Paemeleire, Koen J Headache Pain Case Report BACKGROUND: Cluster headache is classified as a primary headache by definition not caused by an underlying pathology. However, symptomatic cases of otherwise typical cluster headache have been reported. CASE PRESENTATION: A 47-year-old male suffered from primary chronic cluster headache (CCH, ICHD-3 beta criteria fulfilled) since the age of 35 years. A magnetic resonance imaging (MRI) study of the brain in 2006 came back normal. He tried several prophylactic treatments but was never longer than 1 month without attacks. He was under chronic treatment with verapamil with only a limited effect on the attack frequency. Subcutaneous sumatriptan 6 mg injections were very effective in aborting attacks. By February 2014 the patient developed a continuous interictal pain ipsilateral to the right-sided cluster headache attacks. An indomethacin test (up to 225 mg/day orally) was negative. Because of the change in headache pattern we performed a new brain MRI, which showed a cystic structure in the pituitary gland. The differential diagnosis was between a Rathke cleft cyst and a cystic adenoma. Pituitary function tests showed an elevated serum prolactin level. A dopamine agonist (cabergoline) was started and the headache subsided completely. Potential pathophysiological mechanisms of pituitary tumor-associated headache are discussed. CONCLUSION: Neuroimaging should be considered in all patients with CCH, especially those with an atypical presentation or evolution. Response to acute treatment does not exclude a secondary form of cluster headache. There may be shared pathophysiological mechanisms of primary and secondary cluster headache. Springer Milan 2016-03-11 /pmc/articles/PMC4788665/ /pubmed/26969187 http://dx.doi.org/10.1186/s10194-016-0614-0 Text en © De Pue et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report De Pue, Annelien Lutin, Bart Paemeleire, Koen Chronic cluster headache and the pituitary gland |
title | Chronic cluster headache and the pituitary gland |
title_full | Chronic cluster headache and the pituitary gland |
title_fullStr | Chronic cluster headache and the pituitary gland |
title_full_unstemmed | Chronic cluster headache and the pituitary gland |
title_short | Chronic cluster headache and the pituitary gland |
title_sort | chronic cluster headache and the pituitary gland |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788665/ https://www.ncbi.nlm.nih.gov/pubmed/26969187 http://dx.doi.org/10.1186/s10194-016-0614-0 |
work_keys_str_mv | AT depueannelien chronicclusterheadacheandthepituitarygland AT lutinbart chronicclusterheadacheandthepituitarygland AT paemeleirekoen chronicclusterheadacheandthepituitarygland |